# A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)

> **NCT04783181** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Adrenas Therapeutics Inc** · enrollment: 8 (estimated)

## Conditions studied

- Congenital Adrenal Hyperplasia

## Interventions

- **BIOLOGICAL:** AAV BBP-631

## Key facts

- **NCT ID:** NCT04783181
- **Lead sponsor:** Adrenas Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-01
- **Primary completion:** 2029-02
- **Final completion:** 2029-02
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04783181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04783181, "A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04783181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*